Should the gathering of experts from around the world that's considering the scientific, ethical, and governance issues linked to research into gene editing ring alarm bells?
While gene editing offers the exciting potential for disease therapies, using it on human embryos opens up a can of worms.
Despite predictions, the CRISPR/Cas9 gene editing technique didn't win the Nobel Prize. But with the technology nevertheless taking off, it is time we start having an informed public debate about it.
Until more is understood, it's sensible to limit experimentation that would make changes to germ line cells that would be passed on to future generations.